Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Civil society demands probe into HIV, TB funds diversion

Civil society raises concerns over allegations that money for HIVAids and TB programmes was diverted to other health care spending.

Civil society demands probe into HIV, TB funds diversion

Civil society groups have called for an investigation into allegations that funds intended for HIV/Aids, tuberculosis (TB) and other critical health programmes are being diverted to other expenses. Lindiwe Mahlangu, a health expert and member of Positive Women Network, stated that any reallocation of funds could have serious consequences for those already facing gaps in services.

These allegations emerged after the national department of health reportedly escalated claims that money for key health care programmes, including HIV/Aids, TB and child nutrition, was being redirected to health marketing and communication contracts. While Mahlangu acknowledged that the claims had not yet been proven, she emphasized the importance of civil society demanding transparency and accountability.

She highlighted the impact of funding disruptions, particularly following the withdrawal of the President’s Emergency Plan for Aids Relief (Pepfar), which led to gaps in services such as HIV testing, treatment literacy and community mobilisation. Themba Godi, leader of the African People’s Convention and former chair of the public accounts committee, criticized the diversion of funds as poor planning, which could adversely affect service delivery in the long run.

Outa CEO Wayne Duvenage termed the alleged corruption as outrageous and called for officials involved to be identified and investigated, along with scrutiny of companies receiving the contracts. The matter has been referred to the Special Investigating Unit (SIU), the auditor-general and the public protector to examine the irregularities related to New Healthcare Infrastructure (NHI) spending.

Written by urgent.news from The Citizen's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at citizen.co.za →

More in Health & Medicine

GC Cell Publishes Glioblastoma CIK Study

Academic evidence has been established for the utilization of Cytokine-Induced Killer (CIK) cells in the treatment of glioblastoma (GBM), a representative malignant brain tumor occurring in adults.

  • GC Cell study on CIK cells published in Frontiers in Neurology on October 1st
  • Median progression-free survival of 10.5 months, median overall survival of 14.2 months
  • No treatment discontinuation due to adverse reactions, no severe allergic reactions or fatalities

More from Thursday 1 October →